Gxene Biotech has been deeply engaged in antibody research for many years and has established a comprehensive antibody engineering platform. Antibody engineering refers to the engineering of modifying and reassembling antibody genes using recombinant DNA and protein engineering technologies, expressing antibody molecules after transfection into appropriate recipient cells, or modifying antibody molecules by cell fusion, chemical modification, and other methods. Traditional monoclonal antibody drugs have multiple deficiencies such as a single target and weak killing function. Antibody molecules modified by antibody engineering can retain (or increase) the specificity and main biological activities of natural antibodies, remove (or reduce or replace) irrelevant structures, and have good application prospects in the field of pharmaceutical R&D.
Gxene Biotech has successfully developed its own antibody production and modification platform by leveraging its accumulated knowledge and experience in antibody and protein structure-function relationships, combined with mature bioinformatics prediction capabilities and phage library display technology. At present, we have four major platforms: monoclonal antibody preparation service platform, polyclonal antibody preparation service platform, phage antibody library technology platform, and Antibody Sequencing and Application Platform.
Monoclonal Antibody Preparation Service Platform:
Gxene Biotech can provide customers with high-quality monoclonal antibody preparation services. We have been engaged in antibody preparation for many years, accumulated rich experience in monoclonal antibody preparation, and continuously optimized antibody production processes. The delivered monoclonal antibodies can be used for downstream experiments such as IP, Co-IP, ELISA, and IHC.
To meet the needs of different customers, we can provide both traditional antibody preparation and identification services, such as mouse hybridoma preparation services; at the same time, with the phage antibody library platform, we can also provide monoclonal antibody preparation services for customers from multiple species sources such as human, mouse, rabbit, chicken, goat, bovine, alpaca, and shark.
Comparison of Phage Technology and Hybridoma Technology for Monoclonal Antibody Preparation:
|
Hybridoma Technology
|
Phage Technology
|
|
Strong antibody specificity
|
Facilitates directed screening and affinity maturation
|
|
Long development history, mature technology
|
Short preparation time, large-scale production achievable through fermentation
|
|
Simple and stable operation, easier to promote and popularize
|
Can directly provide antibody DNA sequences, facilitating genetic engineering modification
|
Polyclonal Antibody Preparation Service Platform:
Gxene Biotech has deep experience in antibody preparation and comprehensive protein expression and peptide synthesis systems, and can provide polyclonal antibody preparation services for multiple species. We can provide customers with a full set of customized services, including personalized immunization protocols, serum collection, antibody titer evaluation, and antibody purification and modification, etc.
Polyclonal Antibody Preparation Workflow:

Phage Antibody Library Technology Platform:
Gxene Biotech can provide one-stop technical services such as antibody humanization, antibody library construction, antibody fragment library construction, camel immunized VHH antibody library construction, and antibody affinity maturation. Natural or immune-derived antibody libraries established based on M13 phage surface display technology, using different screening strategies such as antigen concentration gradient reduction and direct screening with overexpressing cells, can obtain monoclonal or polyclonal antibodies with high specificity and high affinity (affinity up to 0.5 ppb), and can improve the development success rate of diagnostic reagent-grade antibodies.
Compared with traditional human monoclonal antibody development procedures, by using phage library technology combined with our recombinant protein expression platform, we can effectively custom-develop fully human monoclonal antibody hybridomas for customers and continuously produce high-yield monoclonal antibodies.
Preparation Workflow Using Phage Library Technology:

Antibody Sequencing and Application Platform:
Gxene Biotech has deep knowledge reserves in antibody R&D. Our scientists can provide customers with relatively systematic downstream antibody engineering services, including antibody purification, antibody pairing (custom ELISA development), antibody-antigen binding kinetics research, antibody sequencing, and Antibody Modification, etc.
Our Service Advantages:
–Fast and reliable experimental, analytical, and delivery speed;
–High library capacity and personalized library panning strategies;
–Multiple phage display systems: M13, T4, T7;
–Complete upstream and downstream services: provide one-stop technical services from antibody preparation, antibody sequencing, antibody labeling and modification, to antibody humanization, saving customers' valuable time and funding;
–Customizable services: tailor complete experimental solutions according to customer needs, saving your valuable time and experimental funding.